These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37841365)

  • 101. Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic.
    Guruprasad L; Naresh GK; Boggarapu G
    Curr Res Struct Biol; 2023; 6():100107. PubMed ID: 37841365
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development.
    Guruprasad K
    Curr Res Struct Biol; 2022; 4():41-50. PubMed ID: 35156058
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern.
    Shajahan A; Pepi LE; Kumar B; Murray NB; Azadi P
    Sci Rep; 2023 Jun; 13(1):10053. PubMed ID: 37344512
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis.
    Kumar R; Srivastava Y; Muthuramalingam P; Singh SK; Verma G; Tiwari S; Tandel N; Beura SK; Panigrahi AR; Maji S; Sharma P; Rai PK; Prajapati DK; Shin H; Tyagi RK
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112836
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches.
    Ahmadi S; Bazargan M; Elahi R; Esmaeilzadeh A
    Mol Immunol; 2023 Apr; 156():10-19. PubMed ID: 36857806
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Competition of SARS-CoV-2 variants on the pandemic transmission dynamics.
    Chen J; Gu C; Ruan Z; Tang M
    Chaos Solitons Fractals; 2023 Apr; 169():113193. PubMed ID: 36817403
    [TBL] [Abstract][Full Text] [Related]  

  • 110. SARS-CoV-2 variant biology: immune escape, transmission and fitness.
    Carabelli AM; Peacock TP; Thorne LG; Harvey WT; Hughes J; ; Peacock SJ; Barclay WS; de Silva TI; Towers GJ; Robertson DL
    Nat Rev Microbiol; 2023 Mar; 21(3):162-177. PubMed ID: 36653446
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Urgent Need for Next-Generation COVID-19 Vaccines.
    Marks PW; Gruppuso PA; Adashi EY
    JAMA; 2023 Jan; 329(1):19-20. PubMed ID: 36484995
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Evaluating novel COVID-19 vaccines in the current chapter of the pandemic.
    GeurtsvanKessel CH; de Vries RD
    Lancet Infect Dis; 2022 Dec; 22(12):1652-1654. PubMed ID: 36075232
    [No Abstract]   [Full Text] [Related]  

  • 113. Two Years into the COVID-19 Pandemic: Lessons Learned.
    da Silva SJR; do Nascimento JCF; Germano Mendes RP; Guarines KM; Targino Alves da Silva C; da Silva PG; de Magalhães JJF; Vigar JRJ; Silva-Júnior A; Kohl A; Pardee K; Pena L
    ACS Infect Dis; 2022 Sep; 8(9):1758-1814. PubMed ID: 35940589
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Principles of SARS-CoV-2 glycosylation.
    Chawla H; Fadda E; Crispin M
    Curr Opin Struct Biol; 2022 Aug; 75():102402. PubMed ID: 35717706
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.